First Graphene advances material processing understanding

Industrial materials producer First Graphene (ASX: FGR) has announced progress in its development of production processes used in making graphene oxide suitable for a number of industrial applications. Conventional processing to create dispersible graphene solutions utilise strong acids. First Graphene subsidiary 2D Fluidics Pty Ltd, Flinders University and the UK Graphene Engineering and Innovation Centre…

Interconnector likely to cut electricity costs

The Australian Energy Regulator (AER) has given approval for construction of an interstate electricity connector which has the potential of stimulating green-power investment and lowering eastern state power prices. The AER today approved the new South Australia-New South Wales interconnector, which will connect wind and solar production in South Australia with the east’s major electricity…

Bisalloy partners for market expansion

High strength steel manufacturer Bisalloy (ASX: BIS) is partnering with Singaporean/Chinese manufacturer Leong Jin (Changzhou) Special Steel to better penetrate Australian and South-East Asian steel markets. Bisdalloy will complement its range with Leong Jin product in Australia and the two companies will jointly pursue sales and distribution opportunities in Thailand, Indonesia and New Zealand. Bisalloy…

Lithium Australia wins backing for battery cathode production

The Advanced Manufacturing Growth Centre has backed Lithium Australia’s development of a battery cathode manufacturing capability. AMGC will co-fund a project with Brisbane’s VSPC, a subsidiary of Lithium Australia (ASX: LIT) to develop its technology to manufacture lithium ferro phosphate cathode material from recycled material. Lithium Australia is developing a circular economy approach to mining,…

Anatara Lifesciences gets good news on GaRP supplement

Anatara Lifesciences (ASX:ANR) has released encouraging pre-clinical trial data of its Gastrointestinal ReProgramming (GaRP) dietary supplement which targets diarrhoea. The company is now targeting the second half of this year for human trials of GaRP which treats underlying causes such as irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD). “Anatara believes its GaRP dietary…

Admedus receives approval for human heart valve implants

Heart surgery product developer Admedus (ASX: AHZ) has received approvals for its first in-human trial at Leuven University Hospital of the company’s proprietary ADAPT single-piece 3D aortic valve. The Belgian surgeon Professor Bart Meuris will conduct the trial of 15 patients who will be followed up six month after receiving the ADAPT implant. Results of…